409 Development of ex vivo precision gene engineered B cell medicines that produce highly active and sustained levels of transgenic anti-tumor biologics
oleh: Richard A Morgan, David J Rawlings, Richard G James, Jasmine N Edelstein, Tyler F Hill, Michael D Leiken, Katherine M Molloy, Glory Adekanye, Caroline Bullock, Adam S Lazorchak, Ken-Edwin Aryee, Sean P Arlauckas
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2023-11-01 |
Deskripsi
No description available for this item.